GAMMA Investing’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Buy
1,639
+49
+3% +$3.53K ﹤0.01% 1658
2026
Q1
$113K Buy
1,590
+66
+4% +$4.51K 0.01% 1572
2025
Q4
$90.2K Buy
1,524
+432
+40% +$23.4K ﹤0.01% 1656
2025
Q3
$60.3K Buy
1,092
+40
+4% +$2.08K ﹤0.01% 1860
2025
Q2
$45.3K Sell
1,052
-85
-7% -$3.28K ﹤0.01% 1992
2025
Q1
$45K Buy
1,137
+618
+119% +$27.3K ﹤0.01% 1863
2024
Q4
$21.1K Buy
519
+56
+12% +$2.33K ﹤0.01% 2238
2024
Q3
$18.1K Sell
463
-252
-35% -$10K ﹤0.01% 2168
2024
Q2
$31.3K Sell
715
-142
-17% -$6.86K ﹤0.01% 1542
2024
Q1
$40.9K Sell
857
-89
-9% -$4K 0.01% 1173
2023
Q4
$41.2K Buy
+946
New +$39.3K 0.01% 1016

Other funds holding NGVT

GAMMA Investing's NGVT Position: Q2 2026 in Review

GAMMA Investing increased its Ingevity (NGVT) stake by 3.1% in Q2 2026, buying an estimated $3.53K and bringing the position to 1,639 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

GAMMA Investing first reported a position in NGVT in Q4 2023 and has held it in 11 quarters since. 44 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • GAMMA Investing held 1,639 shares of Ingevity worth $122K as of Q2 2026.
  • GAMMA Investing bought 49 Ingevity shares in Q2 2026, an estimated $3.53K.
  • Ingevity made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1658 holding.
  • GAMMA Investing first reported a position in Ingevity in Q4 2023 and has held it in 11 quarters since.
  • 44 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.